Skip to content

CRVSCORVUS PHARMACEUTICALS INC

CUSIP 221015100 · common stock

3 tracked investors held CORVUS PHARMACEUTICALS INC (CRVS) at the end of Q3 2026, worth $42.2M in total. The largest holder was Perceptive Advisors, with 0.5% of its portfolio. Ken Fisher opened a new position this quarter.

Holders · Q3 2026
3
New holders
1
Value held
$42.2M
Quarter-end price (est.)
$11.52

Investors holding CRVS · Q3 2026

InvestorWeightSharesValueChange
Perceptive Advisors
Perceptive Advisors LLC
0.50%2,510,441$28.9MREDUCE-5.9%
Ken Fisher
Fisher Asset Management, LLC
0.00%1,040,606$12MNEW
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.05%112,100$1.3MREDUCE-4.3%

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
RA Capital Management0.06%450,000$6.7MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026311$42.2M$11.52
Q2 2026300$48.3M$14.94
Q1 2026310$41.4M$14.63
Q4 2025200$8.9M$7.70